These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 2935328

  • 1. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF, Valdes AM, Reddy PS.
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of novel inotropic agents in the treatment of heart failure.
    LeJemtel TH, Keren G, Reis D, Sonnenblick EH.
    J Cardiovasc Pharmacol; 1986 Mar; 8 Suppl 9():S47-54. PubMed ID: 2433542
    [Abstract] [Full Text] [Related]

  • 7. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
    Lellouche D, Delorme G, Merlet P, Dubois-Randé JL, Duval AM, Tarral A, Bourdarias JP, Vernant P.
    Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B, Bouchoucha H, Scholl JM, Hennetier G, Benacerraf A, Achard F, Bock F.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
    [Abstract] [Full Text] [Related]

  • 12. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M, Rochiccioli JP, Edouard P, Fourcade J, Massabuau P, Puel J, Fauvel JM, Bounhoure JP.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparison of the hemodynamic effects of dobutamine and enoximone in the treatment of low cardiac output after valvular surgery].
    George M, Atallah G, Lehot JJ, Bastien O, Durand PG, Estanove S.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():57-62. PubMed ID: 2147836
    [Abstract] [Full Text] [Related]

  • 15. Long-term enoximone therapy in unstable chronic heart failure.
    Treese N, Rhein S, Erbel R, Meyer J.
    J Cardiovasc Pharmacol; 1989 Sep; 14 Suppl 1():S78-83. PubMed ID: 2480491
    [Abstract] [Full Text] [Related]

  • 16. Chronic therapy of severe heart failure with enoximone.
    Gilfrich HJ, Witzke-Gross J, Römer A.
    J Cardiovasc Pharmacol; 1989 Sep; 14 Suppl 1():S75-7. PubMed ID: 2480490
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
    Birnbaum DE, Preuner JG, Gieseke R, Kasper-König W, Trenk D, Jähnchen E, Dieterich HA.
    Z Kardiol; 1991 Sep; 80 Suppl 4():47-52. PubMed ID: 1833897
    [Abstract] [Full Text] [Related]

  • 20. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL, Likoff MJ, Janicki JS, Laskey WK, Hirshfeld JW, Weber KT.
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.